Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Alzheimer's Disease

  Free Subscription


23.09.2019

2 Brain
1 J Biol Chem
1 J Neurol
1 J Neurosci
1 Lancet Neurol
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Brain

  1. PANZA F, Lozupone M, Solfrizzi V, Watling M, et al
    Time to test antibacterial therapy in Alzheimer's disease.
    Brain. 2019 Aug 29. pii: 5556366. doi: 10.1093.
    PubMed     Text format     Abstract available

  2. KULLMANN DM
    Editorial.
    Brain. 2019;142:227.
    PubMed     Text format    


    J Biol Chem

  3. SEIDLER PM, Boyer DR, Murray KA, Yang TP, et al
    Structure-based inhibitors halt prion-like seeding by Alzheimer's disease- and tauopathy-derived brain tissue samples.
    J Biol Chem. 2019 Sep 19. pii: RA119.009688. doi: 10.1074/jbc.RA119.009688.
    PubMed     Text format     Abstract available


    J Neurol

  4. LAGARDE J, Olivieri P, Caille F, Gervais P, et al
    [(18)F]-AV-1451 tau PET imaging in Alzheimer's disease and suspected non-AD tauopathies using a late acquisition time window.
    J Neurol. 2019 Sep 18. pii: 10.1007/s00415-019-09530.
    PubMed     Text format     Abstract available


    J Neurosci

  5. BONDS JA, Shetti A, Bheri A, Chen Z, et al
    Depletion of Caveolin-1 in Type-2 Diabetes Model Induces Alzheimer's disease Pathology Precursors.
    J Neurosci. 2019 Sep 16. pii: JNEUROSCI.0730-19.2019.
    PubMed     Text format     Abstract available


    Lancet Neurol

  6. FRISONI GB, Ritchie C, Carrera E, Nilsson P, et al
    Re-aligning scientific and lay narratives of Alzheimer's disease.
    Lancet Neurol. 2019;18:918-919.
    PubMed     Text format    


    PLoS One

  7. MOORE PJ, Lyons TJ, Gallacher J
    Using path signatures to predict a diagnosis of Alzheimer's disease.
    PLoS One. 2019;14:e0222212.
    PubMed     Text format     Abstract available

  8. BENITO-LEON J, Contador I, Vega S, Villarejo-Galende A, et al
    Non-steroidal anti-inflammatory drugs use in older adults decreases risk of Alzheimer's disease mortality.
    PLoS One. 2019;14:e0222505.
    PubMed     Text format     Abstract available


  9. Correction: Comparison of neurodegenerative types using different brain MRI analysis metrics in older adults with normal cognition, mild cognitive impairment, and Alzheimer's dementia.
    PLoS One. 2019;14:e0222852.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: